Medication Management Services Clause Samples
The Medication Management Services clause outlines the responsibilities and procedures for overseeing a patient's use of prescribed medications. It typically details how healthcare providers will review, monitor, and adjust medication regimens to ensure safety and effectiveness, and may include requirements for regular consultations or documentation. This clause serves to promote patient safety, optimize therapeutic outcomes, and reduce the risk of medication errors or adverse drug interactions.
Medication Management Services. The Contractor shall allow PCPs to provide medication management services (prescriptions, medication monitoring visits, laboratory and other diagnostic tests necessary for diagnosis and treatment of behavioral disorders) to members with diagnoses of depression, anxiety and Attention Deficit Hyperactivity Disorder (ADHD). The Contractor shall make available, on the Contractor’s formulary, medications for the treatment of these disorders. The Contractor is responsible for these services both in the prospective and prior period coverage timeframes.
Medication Management Services. CONTRACTOR shall provide Medication Management Services which include evaluation of need for medication; evaluation of clinical 16 effectiveness and side effects of medication; obtaining informed consent; medication education including 17 discussing risks, benefits, and alternatives with the Consumers or significant support persons; plan 18 development related to the delivery of services and/or to the status of the Consumer’s community functioning; and prescribing, dispensing, and administering of psychiatric medications. Medication 19 Management Services shall be provided by a licensed physician with a specialty in psychiatry or by a 20 licensed RN, NP, or an LPT under the supervision of a licensed psychiatrist, and in accordance with their scope of practice, CONTRACTOR is encouraged to follow COUNTY’s prescribing guidelines.
Medication Management Services. 50.1. The parties to the Agreement, together with the Society, acknowledge that there are benefits in pharmacists working cooperatively with general practitioners and other members of the healthcare team to address medication related needs of members of the community. Community pharmacists’ contribution to patient care is based on their specialised knowledge and expertise, and includes the provision of Medication Management Services (MMS) in residential aged care and domiciliary settings.
50.2. Many individuals in the community are at particular risk of drug misadventure because of the nature of their illness, the characteristics of the medication they are taking and the complexity of their drug treatment regimen. Medication Management Services promote health, reduce the risk of drug misadventure and optimise the benefits achieved from drug treatment by focussing on the achievement of quality use of medicines.
50.3. This Agreement builds on previous arrangements for delivery of medication review by incorporating several new elements which will be phased in over the life of the Agreement. The program will encompass the following elements:
a) MMS to residents of Residential Aged Care Facilities;
b) Domiciliary MMS;
c) Case discussions and care planning; and
d) Pharmacist facilitators in Divisions of General Practice.
50.4. This program will be funded to the level of $ 114 million over the life of the Agreement. These funds may be moved between the elements of the program and between years.
50.5. Collaboration between the patient's usual general practitioner and pharmacy and with the accredited pharmacist providing MMS is an essential element for effective service delivery. The enhanced communication achieved through collaboration is integral to ensuring the service is appropriate to the patient's needs and promotes greater uptake of the recommendations arising from the service. It also establishes the professional rapport required for team based care.
50.6. For these reasons, and to optimise the benefits to patients receiving Medication Management Services, the pharmacy and medical professions must work closely together in developing and implementing the MMS program and its materials and protocols. To this end the AMC will ensure that a steering committee, which includes representatives from the medical profession and other key stakeholders, is formed to oversee the development of protocols for the MMS and provide direction and leadership for implementation ...
Medication Management Services. 4.13.1 For members determined to have a SMI, the Contractor shall allow PCPs to treat members diagnosed with anxiety, depression and Attention Deficit Hyperactivity Disorder (ADHD). For purposes of medication management, it is not required that the PCP be the member’s assigned PCP. PCP’s who treat members with these behavioral health conditions may provide medication management services including prescriptions, laboratory and other diagnostic tests necessary for diagnosis, and treatment. The Contractor shall make available, on the Contractor’s formulary, medications for the treatment of these disorders. The Contractor is responsible for these services both in the prospective and prior period coverage timeframes.
Medication Management Services. Your signature upon the Authorization for Client Consent for Treatment Form indicates consent for treatment by the family mental health nurse practitioner to provide therapy and medication management. Written consent need only be obtained one time for all subsequent care given by the nurse practitioner to the client in this office, though this needs to be updated annually. A minor under 18 and adults under guardianship must have a legal guardian in attendance for each appointment unless other arrangements have been made with your provider. No medication will be initiated or changed without the consent and knowledge of the legal guardian.